1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. LYELL IMMUNOPHARMA INC
Lyell Immunopharma Inc XNAS: LYEL

Lyell Immunopharma Inc Live Stock Price Today, Share Analysis and Chart

about

Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline include...

Read More
24.50 -0.64 (-2.55%)
45.56% Fall from 52W High
46,523.0
XNAS Volume

XNAS 12 Mar, 2026 1:13 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The latest board meeting for Lyell Immunopharma Inc took place on 11 Mar 2026, for the purpose of Lyell Immunopharma Inc Annual Report for 2025 See details
Durability score
Not Eligible
Valuation Score
Expensive Valuation
11.5 / 100
Momentum Score
Technically Moderately Bullish
64.8 / 100
Analyst Price Target
31
1Yr Price target upside is 26%
4 analysts

11

S

10

W

5

O

0

T

SWOT Analysis

Lyell Immunopharma Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..